neobookRx
DrugsLevel 4 LocalisationS3CAPEML

Ketoprofen

NSAIDAnalgesic, Anti-inflammatory, Antirheumatic

Indications

Registered South African indications:

  • Pain
  • Inflammation

Cautions

Contraindications 

  • Hypersensitivity to the active ingredient or any of its excipients
  • The third trimester of pregnancy
  • Severe renal impairment
  • Severe hepatic impairment
  • History of hypersensitivity reactions such as bronchospasm, asthmatic attacks, rhinitis, angioedema, urticaria or other allergic-type reactions to ketoprofen, any other ingredients in this medicine, acetylsalicylic acid or other non-steroidal anti-inflammatory drugs. Severe, rarely fatal, anaphylactic reactions have been reported in such patients
  • Severe heart failure
  • Active peptic ulcer or any history of gastrointestinal bleeding, ulceration or perforation
  • Haemorrhagic diathesis

Cautions 

  • Pregnancy <30 weeks
  • Breastfeeding
  • Mild to moderate renal impairment
  • Mild to moderate hepatic impairment
  • Elderly
  • History of hypertension
  • Mild to moderate congestive heart failure
  • Ischaemic heart disease
  • Peripheral arterial disease
  • Cerebrovascular disease
  • Respiratory disorders
  • Gastrointestinal bleeding, ulceration and perforation
  • Systemic lupus erythematosus and mixed connective tissue disease
  • Dehydration 

Adult dosage

Forms avail. in SA in this monograph: ER cap

Rheumatoid arthritis
Osteoarthritis 

  • Oral (ER cap): 200mg, dly

Take with food or milk 


Ketoflam (sustained-release capsules) is not intended for initial therapy

Paediatric dosage

Not established for use in children

Special populations

Adverse reactions

Central Nervous System Disorders

  • Headache
  • Dizziness
  • Somnolence
  • Paraesthesia
  • Convulsions
  • Dysgeusia
  • Depression
  • Confusion
  • Hallucinations
  • Vertigo
  • Malaise
  • Drowsiness
  • Aseptic meningitis 

Cardiovascular Disorders

  • Heart failure
  • Oedema
  • Hypertension
  • Vasodilatation

Respiratory Disorders

  • Asthma
  • Bronchospasm 
  • Rhinitis
  • Non-specific allergic reactions
  • Dyspnoea

Gastrointestinal Disorders

  • Dyspepsia
  • Nausea and vomiting
  • Abdominal pain
  • Constipation
  • Diarrhoea
  • Flatulence
  • Gastritis
  • Stomatitis
  • Peptic ulcer
  • Pancreatitis 
  • Exacerbation of colitis and Crohn's disease
  • Gastrointestinal haemorrhage
  • Perforation
  • Melaena
  • Haematemesis
  • Gastrointestinal bleeding 

Hepatobiliary Disorders

  • Hepatitis
  • Increased serum transaminases
  • Elevated serum bilirubin
  • Abnormal liver function
  • Jaundice

Genitourinary Disorders

  • Renal failure
  • Tubulointerstitial nephritis
  • Nephritic syndrome

Skin and Subcutaneous Tissue Disorders

  • Pruritis
  • Photosensitivity reactions
  • Alopecia
  • Urticaria
  • Angioedema
  • Bullous eruption 
  • Stevens-Johnson syndrome 
  • Toxic epidermal necrolysis 
  • Exfoliative and bullous dermatoses 
  • Purpura

Immune, Blood and and Lymphatic System Disorders

  • Haemorrhagic anaemia
  • Agranulocytosis
  • Thrombocytopenia
  • Bone marrow failure
  • Neutropenia
  • Anaphylactic reactions

Sensory Disorders

  • Visual disturbances such as blurred vision 
  • Optic neuritis
  • Tinnitus

Interactions

  • Anticoagulants 
  • Platelet aggregation inhibitors 
  • Methotrexate
  • Lithium
  • Non-steroidal anti-inflammatory drugs 
  • Mifepristone
  • Pentoxifylline
  • Diuretics
  • Cardiac glycosides
  • Ciclosporin
  • Corticosteroids
  • Quinolone antibiotics
  • Tacrolimus
  • Thrombolytic agents
  • Probenecid
  • Selective serotonin reuptake inhibitors 
  • Angiotensin-converting enzyme inhibitors
  • Angiotensin II blockers
  • Zidovudine

Monitoring

None routine. Specific cases may require

  • Renal function
  • Hepatic function

Mechanism of action

Inhibits prostaglandin synthesis by inhibition of cyclooxygenase.

Dosage forms

  • Capsule

Formulation

Capsule sr 200mg

  • Ketoflam (Adcock) originator

Also available in the following form: Gel.

References

1. SAMF_12th Edition_Page 400 2. https://www.medicines.org.uk/emc/medicine/25503 21 October 2013_ SANOFI 3. http://home.intekom.com/pharm/adcock/ketoflam.html January 1996_SR 4. https://www.drugs.com/dosage/ketoprofen.html 5. https://drive.google.com/drive/folders/0B0xnChtF7vduZGtHeHgwd1Flb0k (10/01/1996_Ketoflam_200mg tab)

Brands & products

4 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days old

JutGeneric· 1 product

from R2.96/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Fastum dispenser pack- g100S1R296.04R2.96R106.65707853001

gelGeneric· 2 products

from R2.96/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Fastum gel- g/100g100S1R296.04R2.96R106.65799351016
Fastum gel- g/100g50S1R162.94R3.26R68.26799351008

capsuleGeneric· 1 product

from R9.13/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Ketoflam200 mg30S3R274.01R9.13R100.59822205009
Trade names (1)
  • Ketoflam

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Interacts with 8 known drugs

Check against other drugs →

Cited in 3 documents

NeoHealth® ID 15674 · updated 9/25/2024